{"slideshow_credits": null, "snippet": "In response to questions raised by the Food and Drug Administration, the medical testing start-up has temporarily stopped its signature practice of collecting tiny blood samples from finger pricks.", "abstract": "Blood testing start-up Theranos temporarily stops its trademark practice of collecting small blood samples from finger pricks; firm faces scrutiny by Food and Drug Administration over its data, as reliability of its test results have been questioned.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}, {"firstname": "Reed", "role": "reported", "lastname": "ABELSON", "rank": 2, "organization": ""}], "original": "By ANDREW POLLACK and REED ABELSON"}, "web_url": "http://www.nytimes.com/2015/10/17/business/theranos-a-blood-test-start-up-faces-fda-scrutiny.html", "lead_paragraph": "In response to questions raised by the Food and Drug Administration, the medical testing start-up has temporarily stopped its signature practice of collecting tiny blood samples from finger pricks.", "headline": {"main": "Theranos, a Blood Test Start-Up, Faces F.D.A. Scrutiny", "print_headline": "Blood Test Start-Up Faces F.D.A. Scrutiny "}, "_id": "56219d1438f0d875be24df1f", "word_count": "805", "multimedia": [{"height": 126, "url": "images/2015/10/17/business/17THERANOS/17THERANOS-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/10/17/business/17THERANOS/17THERANOS-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/10/17/business/17THERANOS/17THERANOS-articleLarge.jpg", "legacy": {"xlarge": "images/2015/10/17/business/17THERANOS/17THERANOS-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/10/17/business/17THERANOS/17THERANOS-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/10/17/business/17THERANOS/17THERANOS-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-10-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Theranos Inc", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Tests (Medical)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Blood", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Start-ups", "is_major": "N", "rank": "5"}, {"name": "persons", "value": "Holmes, Elizabeth (1984- )", "is_major": "N", "rank": "6"}, {"name": "persons", "value": "Boies, David", "is_major": "N", "rank": "7"}, {"name": "subject", "value": "Laboratories and Scientific Equipment", "is_major": "N", "rank": "8"}, {"name": "subject", "value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": null, "type_of_material": "News"}